© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
Reviewing Data on Lenvatinib plus Pembrolizumab Combination Treatment for Advanced Renal Cell Carcinoma - Episode 5
Oncologists debate whether TKI monotherapy has a place in renal cell carcinoma treatment after the CLEAR trial.